- Home
- PALI vs TNON Comparison
PALI vs TNON Comparison
Compare PALI & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PALI
- TNON
- Stock Information
- Founded
- PALI 1996
- TNON 2012
- Country
- PALI United States
- TNON United States
- Employees
- PALI N/A
- TNON N/A
- Industry
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- TNON Medical Specialities
- Sector
- PALI Health Care
- TNON Health Care
- Exchange
- PALI Nasdaq
- TNON Nasdaq
- Market Cap
- PALI 3.2M
- TNON 3.2M
- IPO Year
- PALI N/A
- TNON 2022
- Fundamental
- Price
- PALI $0.72
- TNON $1.12
- Analyst Decision
- PALI Strong Buy
- TNON Strong Buy
- Analyst Count
- PALI 2
- TNON 3
- Target Price
- PALI $23.00
- TNON $11.67
- AVG Volume (30 Days)
- PALI 71.2K
- TNON 19.3M
- Earning Date
- PALI 05-12-2025
- TNON 05-13-2025
- Dividend Yield
- PALI N/A
- TNON N/A
- EPS Growth
- PALI N/A
- TNON N/A
- EPS
- PALI N/A
- TNON N/A
- Revenue
- PALI N/A
- TNON $3,277,000.00
- Revenue This Year
- PALI N/A
- TNON $118.16
- Revenue Next Year
- PALI N/A
- TNON $14.25
- P/E Ratio
- PALI N/A
- TNON N/A
- Revenue Growth
- PALI N/A
- TNON 11.92
- 52 Week Low
- PALI $0.60
- TNON $0.91
- 52 Week High
- PALI $9.09
- TNON $15.79
- Technical
- Relative Strength Index (RSI)
- PALI 45.23
- TNON 44.55
- Support Level
- PALI $0.65
- TNON $1.07
- Resistance Level
- PALI $0.77
- TNON $1.17
- Average True Range (ATR)
- PALI 0.05
- TNON 0.20
- MACD
- PALI 0.02
- TNON -0.06
- Stochastic Oscillator
- PALI 70.59
- TNON 5.75
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities: 1) Primary SI Joint procedures, 2) Revision procedures of failed SI Joint implants, and 3) SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.